Skip to main content
Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
14.31
+0.46 (3.32%)
At close: Mar 9, 2026, 4:00 PM EDT
14.03
-0.28 (-1.96%)
After-hours: Mar 9, 2026, 5:58 PM EDT

Amylyx Pharmaceuticals Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
136
Market Cap
1.58B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 202487.37M-293.42M-77.06%
Dec 31, 2023380.79M358.56M1,612.94%
Dec 31, 202222.23M21.95M7,700.00%
Dec 31, 2021285.00K-365.00K-56.15%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 10.27B
Perrigo Company 4.25B
Phibro Animal Health 1.46B
Evotec SE 887.40M
ANI Pharmaceuticals 883.37M
BioCryst Pharmaceuticals 874.84M
Collegium Pharmaceutical 780.57M
Alvotech 573.35M
Revenue Rankings

AMLX News

More News